© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 16, 1226-1237,
August 21, 2002
© 2002 Oxford University Press
ARTICLE |
The Effects of Adrenomedullin Overexpression in Breast Tumor Cells
Affiliations of authors: A. Martínez, M. Vos, M. Garayoa, R. Pío, T. Moody, F. Cuttitta (Cell and Cancer Biology Branch and Vascular Biology Faculty), L. Guédez, W. G. Stetler-Stevenson (Extracellular Matrix Section, Laboratory of Pathology), National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD; G. Kaur, Biology Testing Branch, Developmental Therapeutics Section, SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD; Z. Chen (Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders), H. K. Kleinman (Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research), NIH.
Correspondence to: Alfredo Martínez, Ph.D., Cell and Cancer Biology Branch, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm. 13N262, Bethesda, MD 20892 (e-mail: martinea{at}mail.nih.gov).
Background: Adrenomedullin is a secreted peptide hormone with multiple activities. Several reports have indicated that adrenomedullin may be involved in tumor survival, but this has not been directly shown. Here we evaluate the in vitro and in vivo effects of adrenomedullin overexpression in human breast cancer cells. Methods: The human breast cancer cell lines T47D and MCF7, both of which express low basal levels of adrenomedullin, were stably transfected with an expression construct that contained the coding region of the human adrenomedullin gene or with empty expression vector. Properties of the transfected cells were assessed by proliferation and apoptosis assays, in vitro and in vivo angiogenesis assays, cell migration experiments, and xenograft implants. The effect of synthetic adrenomedullin on human ovarian (ECV) cancer cell motility was also tested. Western blot analysis was used to compare expression levels of several genes whose products are associated with cell growth and regulation of apoptosis. Results: T47D and MCF7 cells transfected with the adrenomedullin construct both expressed high levels of adrenomedullin mRNA and protein. Compared with cells transfected with empty vector, cells that overexpressed adrenomedullin displayed a more pleiotropic morphology, an increased angiogenic potential both in vitro and in vivo, and less apoptosis after serum deprivation. T47D and MCF7 cells did not display measurable motility, but ECV ovarian cancer cells treated with synthetic adrenomedullin were more motile than saline-treated ECV cells. Adrenomedullin-overexpressing T47D cells had higher levels of proteins involved in oncogenic signal transduction pathways (such as Ras, Raf, PKC, and MAPKp49) and lower levels of pro-apoptotic proteins (such as Bax, Bid, and caspase 8) than T47D cells transfected with empty vector. In a preliminary in vivo experiment, three of 10 nude mice injected with adrenomedullin-overexpressing T47D cells developed xenograft tumors, whereas none of the 10 nude mice injected with cells carrying the empty plasmid developed tumors. Conclusions: These results further support the role of adrenomedullin as a survival factor for tumors. Development of physiologically efficient inhibitors of adrenomedullin may prove useful in the clinical management of cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. L. Sackett, L. Ozbun, E. Zudaire, L. Wessner, J. M. Chirgwin, F. Cuttitta, and A. Martinez Intracellular Proadrenomedullin-Derived Peptides Decorate the Microtubules and Contribute to Cytoskeleton Function Endocrinology, June 1, 2008; 149(6): 2888 - 2898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ribatti, M. T. Conconi, and G. G. Nussdorfer Nonclassic Endogenous Novel Regulators of Angiogenesis Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Nikitenko, T. Cross, L. Campo, H. Turley, R. Leek, S. Manek, R. Bicknell, and M. C.P. Rees Expression of Terminally Glycosylated Calcitonin Receptor-Like Receptor in Uterine Leiomyoma: Endothelial Phenotype and Association with Microvascular Density. Clin. Cancer Res., October 1, 2006; 12(19): 5648 - 5658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Schwarz, D. Renshaw, S. Kapas, and J. P Hinson Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells. J. Endocrinol., August 1, 2006; 190(2): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Martinez, J. A. Bengoechea, and F. Cuttitta Molecular Evolution of Proadrenomedullin N-Terminal 20 Peptide (PAMP): Evidence for Gene Co-Option Endocrinology, July 1, 2006; 147(7): 3457 - 3461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Nikitenko, N. Blucher, S. B. Fox, R. Bicknell, D. M. Smith, and M. C. P. Rees Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms. J. Cell Sci., March 1, 2006; 119(Pt 5): 910 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zudaire, A. Martinez, M. Garayoa, R. Pio, G. Kaur, M. R. Woolhiser, D. D. Metcalfe, W. A. Hook, R. P. Siraganian, T. A. Guise, et al. Adrenomedullin Is a Cross-Talk Molecule that Regulates Tumor and Mast Cell Function during Human Carcinogenesis Am. J. Pathol., January 1, 2006; 168(1): 280 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Notari, A. Miller, A. Martinez, J. Amaral, M. Ju, G. Robinson, L. E. H. Smith, and S. P. Becerra Pigment Epithelium-Derived Factor Is a Substrate for Matrix Metalloproteinase Type 2 and Type 9: Implications for Downregulation in Hypoxia Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2736 - 2747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jelier, G. Jenster, L. C. J. Dorssers, C. C. van der Eijk, E. M. van Mulligen, B. Mons, and J. A. Kors Co-occurrence based meta-analysis of scientific texts: retrieving biological relationships between genes Bioinformatics, May 1, 2005; 21(9): 2049 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Martinez, E. Zudaire, S. Portal-Nunez, L. Guedez, S. K. Libutti, W. G. Stetler-Stevenson, and F. Cuttitta Proadrenomedullin NH2-Terminal 20 Peptide Is a Potent Angiogenic Factor, and Its Inhibition Results in Reduction of Tumor Growth Cancer Res., September 15, 2004; 64(18): 6489 - 6494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ajona, Z. Castano, M. Garayoa, E. Zudaire, M. J. Pajares, A. Martinez, F. Cuttitta, L. M. Montuenga, and R. Pio Expression of Complement Factor H by Lung Cancer Cells: Effects on the Activation of the Alternative Pathway of Complement Cancer Res., September 1, 2004; 64(17): 6310 - 6318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Iimuro, T. Shindo, N. Moriyama, T. Amaki, P. Niu, N. Takeda, H. Iwata, Y. Zhang, A. Ebihara, and R. Nagai Angiogenic Effects of Adrenomedullin in Ischemia and Tumor Growth Circ. Res., August 20, 2004; 95(4): 415 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. MartInez, M. Julian, C. Bregonzio, L. Notari, T. W. Moody, and F. Cuttitta Identification of Vasoactive Nonpeptidic Positive and Negative Modulators of Adrenomedullin Using a Neutralizing Antibody-Based Screening Strategy Endocrinology, August 1, 2004; 145(8): 3858 - 3865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lugassy, H. K. Kleinman, J. A. Engbring, D. R. Welch, J. F. Harms, R. Rufner, G. Ghanem, S. R. Patierno, and R. L. Barnhill Pericyte-Like Location of GFP-Tagged Melanoma Cells: Ex Vivo and In Vivo Studies of Extravascular Migratory Metastasis Am. J. Pathol., April 1, 2004; 164(4): 1191 - 1198. [Abstract] [Full Text] [PDF]
|
|